SlideShare a Scribd company logo
Global Cancer Epidemic: Impact,
Challenges and Future Trends
Thomas Gross, MD, PhD
Deputy Director of Science
Center for Global Health
National Cancer Institute
Bethesda, MD 20892
Email: thomas.gross@nih.gov
Summary of Presentation
• Cancer rates, cancer types & cancer mortality vary widely
around the world
• Eight environmental or lifestyle risk factors that account
for ~50% of all cancer deaths
• Tobacco exposure is by far the most prominent
• Strategies to reduce these risk factors will have a
tremendous impact on reducing the burden of cancer
globally
• Socioeconomic factors affect cancer rates and mortality
and will become a bigger challenge in the future
Fast Facts About Cancer
• Cancer is a global epidemic and a leading
cause of death worldwide, accounting for
7.6 million deaths or around 13% of all
deaths in 2008.
• Worldwide, cancer now causes more deaths
than HIV/AIDS, tuberculosis, and malaria
combined.
• More than 70% of all cancer deaths occur in
low- and middle-income countries.
CANCER RATES, TYPE AND
MORTALITY VARIES WORLDWIDE
Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90
The Worldwide Burden of Cancer in Men
(Top 10 Cancer Sites)
Total: 6,629,100 Total: 4,225,700
Most Common Cancer Site in Males
Source: GLOBOCAN 2008 via the American Cancer Society
Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90
The Worldwide Burden of Cancer in Women
(Top 10 Cancer Sites)
Total: 4,225,700 Total: 3,345,800
Most Common Cancer Site in Females
Source: GLOBOCAN 2008 via the American Cancer Society
CAUSES OF CANCER
VARY WORLDWIDE
80.3
65.9
34.1
33
32.7
25.2
21.5
20.9
19.2
17.7
17.2
17.1
14.7
13.9
13.3
12.3
11
7.1
4.6
3.3
0 10 20 30 40 50 60 70 80 90
Japan, Hiroshima
Korea
China, Shanghai
USA, Los Angeles: Korean
Russia, St Petersburg
Peru, Trujillo
Singapore: Chinese
Slovenia
Brazil, Cuiaba
Poland, Cracow
USA, Hawaii: Japanese
USA, Los Angeles: Japanese
China, Hong Kong
Switzerland, Ticino
France, Manche
Spain, Zaragoza
USA, SEER (9): Black
Algeria, Setif
India, Mumbai
Egypt, Gharbiah
Rate per 100,000
Male Stomach Cancer ASRs from Population-based Registries:
Data Source: Curado. M. P., Edwards, B., Shin. H.R., Storm. H.,
Ferlay. J., Heanue. M. and Boyle. P., eds (2007) Cancer
Incidence in Five Continents, Vol. IX
IARC Scientific Publications No. 160, Lyon, IARC.
http://www-dep.iarc.fr/
Genetic Pre-disposition vs Environment Exposure
Eight Risk Factors Account for 50% of Deaths from Cancer
Risk Factors Vary In Their Contribution
To Cancers In Different Settings
Percentage of
Cancers
Attributable to
Risk Factor
Source: The Cancer Atlas
Diseases Associated with Tobacco Exposure
Lung
Oral
Bladder
Larynx
Esophagus
Pancreas
Colorectal
Stomach
Leukemia
Cervix
Sudden infant death
Fetal death, stillbirth
Reduced fertility
Low birth weight
Pregnancy complications
Lung function in infants
Cardiovascular Diseases
Respiratory Diseases
Asthma control
Low bone density
Erectile Dysfunction
Peptic ulcer disease
Dental diseases
The Health Consequences of Smoking: A Report of the Surgeon General , 2004
Cancers Other Medical Conditions
Infections cause about:
• 18% of cancers
globally
(>2 million cases/year)
• 26% of cancers in
LMICs
• 40% of cancers in
Africa
(from Worldmapper, www.worldmapper.org
Territories are sized
in proportion to the
absolute number of
people who died
from liver cancer
annually
Liver Cancer Kills 1% of the World’s Population
Cancer of the liver cause ~1% of all deaths worldwide (~100 deaths per
million people per year) and 9% of all deaths from cancer.
S. Korea
China
Taiwan
Japan
India
10
IMPACT OF SOCIOECONOMIC
STATUS ON CANCER BURDEN
Data Source: Globocan 2008
Overall (non-adjusted) Cancer Incidence Rates
(Per 100K, Both Genders; All Cancers Except Non-Melanoma Skin)
Annual
Cancer
Cases
(Millions) 5.7 7.4
7.5
12.9
0
5
10
15
20
25
2010 2030
Less Developed
More Developed
57%
64%
Trends in Cancer Incidence
Developed vs. Less Developed Countries
Data derived from GLOBOCAN
2008
0
500
1000
1500
2000
2500
Ages <
20
Ages
20-49
Ages
50-64
Ages
65-74
Ages
75+
Data from SEER 2010
Cancer incidence with age in USA
Cancer in 0-14 yr olds as % of all cancer
Globocan 2002
%
of
All
Cancers
• Incidence per capita of pediatric cancer is similar around the world
Trends in Cancer Mortality
Developed vs. Less Developed Countries
 Cancer mortality in more developed countries
 projected decrease by <30% by 2030
 Cancer mortality in less developed countries
 projected to increase by >70% by 2030
By 2030 - 85% of all cancer deaths may be occurring in low-middle income
countries
 The increase In cancer mortality in LMIC is largely due to:
 Delay in accurate diagnoses
 Lack of unawareness about cancer and potential value of therapy
 Lack of access and ability to deliver potentially curative therapy
 Abandonment of therapy
Data Source: Globocan 2008
Female Breast Cancer Incidence
(Per 100,000)
Total Expenditure on Health
(for 2011 in US$)
Breast Cancer and Socioeconomic Status
RISK FACTORS FOR BREAST CANCER IN
DEVELOPED COUNTRIES
• Higher maternal age at first birth
• Reduced parity
– Each live birth results in a decrease
of 7% in relative risk of breast
cancer (Lancet 2002;360:187-195)
• Reduced breast feeding
– For every 12 months of breast
feeding results in a decrease of 4%
in relative risk of breast cancer
(Lancet 2002;360:187-195)
• Obesity & “lifestyle” factors
Incidence of Breast Cancer & Outcomes Correlate with GDP
Source: Harford JB, Lancet Oncol. 2011 Mar;12(3):306-12.
Institute of Medicine (IOM REPORT)
High-income countries should:
•Resist the temptation to focus on exporting the
latest, most expensive technologies that may
be appropriate for wealthy countries…
•Partner with countries to develop resource-
appropriate strategies focused on decreasing
the burden and mortality due to cancer.
IOM Report
Some low- or middle income countries
(including physicians & governments) have a
related temptation to WANT the latest, most
expensive technologies as opposed to more
resource-appropriate “alternatives” which may
be seen as 2nd rate solutions.
A National Cancer Control Program in Context
Broader Social Context
Healthcare System
National Cancer
Control Program
Primary
Prevention
Early
Detection
Palliative
Care
Curative
Treatment
Survivorship
This is for title
• This is for text
NCI - CGH Global Footprint
Acknowledgments
• Ted Trimble, MD, MPH – Director of NCI-CGH
• Lisa Stevens, PhD – Deputy Director of NCI-CGH
• Joe Harford, PhD - Senior Advisor NCI-CGH
• Ann Chao, PhD – East Asia Representative, NCI-CGH
51071.ppt

More Related Content

Similar to 51071.ppt

Jgh3 4-351
Jgh3 4-351Jgh3 4-351
Jgh3 4-351
rakeshsrivastava89
 
Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)
Dr. Tajali Nazir Shora
 
Cancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul ShrivastavaCancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul Shrivastava
Drrahul Shrivastava
 
Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)
Thanos Andriopoulos
 
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCEREFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
Dr Christa Maria Joel MBBS MPH MRSPH
 
Maria wey2 hw215 - cancer and the allied healthcare worker unit 6 final
Maria wey2   hw215 - cancer and the allied healthcare worker unit 6 finalMaria wey2   hw215 - cancer and the allied healthcare worker unit 6 final
Maria wey2 hw215 - cancer and the allied healthcare worker unit 6 final
Maria Wey
 
Historica perspective and epidemiology related to cancer ppt
Historica perspective and epidemiology related to cancer pptHistorica perspective and epidemiology related to cancer ppt
Historica perspective and epidemiology related to cancer ppt
goverment nursing college.
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
RUPESH459599
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
Andrew Kwami
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
Andrew Kwami
 
Breast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistanceBreast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistance
Springer
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancer
Dr.Priyanka Sharma
 
cancer.pdf
cancer.pdfcancer.pdf
cancer.pdf
MarryamFaiz
 
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public HealthKing Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
UWGlobalHealth
 
C A N C E R Gdsj09
C A N C E R Gdsj09C A N C E R Gdsj09
C A N C E R Gdsj09
Andrew Kwami
 
Universal health coverage and the challenge of responding to chronic illness:...
Universal health coverage and the challenge of responding to chronic illness:...Universal health coverage and the challenge of responding to chronic illness:...
Universal health coverage and the challenge of responding to chronic illness:...
Fundación Mexicana para la Salud A.C.
 
7. Oncology.pptx
7. Oncology.pptx7. Oncology.pptx
7. Oncology.pptx
aminacabdi38
 
Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018
JA Larson
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
Rabin Dani
 
Vit D Chart booklet may2016
Vit D Chart booklet may2016Vit D Chart booklet may2016
Vit D Chart booklet may2016
JA Larson
 

Similar to 51071.ppt (20)

Jgh3 4-351
Jgh3 4-351Jgh3 4-351
Jgh3 4-351
 
Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)Cancer burden dr tajali shora (1)
Cancer burden dr tajali shora (1)
 
Cancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul ShrivastavaCancer - Dr.Rahul Shrivastava
Cancer - Dr.Rahul Shrivastava
 
Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)Athanasios Andriopoulos_final (2)
Athanasios Andriopoulos_final (2)
 
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCEREFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
EFFECTS OF LIFESTYLE ON PREVALENCE OF COLORECTAL CANCER
 
Maria wey2 hw215 - cancer and the allied healthcare worker unit 6 final
Maria wey2   hw215 - cancer and the allied healthcare worker unit 6 finalMaria wey2   hw215 - cancer and the allied healthcare worker unit 6 final
Maria wey2 hw215 - cancer and the allied healthcare worker unit 6 final
 
Historica perspective and epidemiology related to cancer ppt
Historica perspective and epidemiology related to cancer pptHistorica perspective and epidemiology related to cancer ppt
Historica perspective and epidemiology related to cancer ppt
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
 
Cancer Gdsj091 Final
Cancer Gdsj091 FinalCancer Gdsj091 Final
Cancer Gdsj091 Final
 
Breast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistanceBreast cancer metastasis and drug resistance
Breast cancer metastasis and drug resistance
 
Risk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancerRisk factors and prevention strategies of oral cancer
Risk factors and prevention strategies of oral cancer
 
cancer.pdf
cancer.pdfcancer.pdf
cancer.pdf
 
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public HealthKing Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
 
C A N C E R Gdsj09
C A N C E R Gdsj09C A N C E R Gdsj09
C A N C E R Gdsj09
 
Universal health coverage and the challenge of responding to chronic illness:...
Universal health coverage and the challenge of responding to chronic illness:...Universal health coverage and the challenge of responding to chronic illness:...
Universal health coverage and the challenge of responding to chronic illness:...
 
7. Oncology.pptx
7. Oncology.pptx7. Oncology.pptx
7. Oncology.pptx
 
Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018Vit D Mrip chart-booklet-08-2018
Vit D Mrip chart-booklet-08-2018
 
Non communicable disease and risk factors
Non communicable disease and risk factorsNon communicable disease and risk factors
Non communicable disease and risk factors
 
Vit D Chart booklet may2016
Vit D Chart booklet may2016Vit D Chart booklet may2016
Vit D Chart booklet may2016
 

More from KhalidBassiouny1

05lipids2009.ppt
05lipids2009.ppt05lipids2009.ppt
05lipids2009.ppt
KhalidBassiouny1
 
2-lipid.ppt
2-lipid.ppt2-lipid.ppt
2-lipid.ppt
KhalidBassiouny1
 
2-12-2012-2.ppt
2-12-2012-2.ppt2-12-2012-2.ppt
2-12-2012-2.ppt
KhalidBassiouny1
 
2-12-2012.ppt
2-12-2012.ppt2-12-2012.ppt
2-12-2012.ppt
KhalidBassiouny1
 
PeptidesandProteins.ppt
PeptidesandProteins.pptPeptidesandProteins.ppt
PeptidesandProteins.ppt
KhalidBassiouny1
 
PBIO4500 Protein Therapeutics.ppt
PBIO4500 Protein Therapeutics.pptPBIO4500 Protein Therapeutics.ppt
PBIO4500 Protein Therapeutics.ppt
KhalidBassiouny1
 
Nut_Chapter_6_lecture.ppt
Nut_Chapter_6_lecture.pptNut_Chapter_6_lecture.ppt
Nut_Chapter_6_lecture.ppt
KhalidBassiouny1
 
Lh6Ch03aAAs.ppt
Lh6Ch03aAAs.pptLh6Ch03aAAs.ppt
Lh6Ch03aAAs.ppt
KhalidBassiouny1
 
Lecture 14 2013.ppt
Lecture 14 2013.pptLecture 14 2013.ppt
Lecture 14 2013.ppt
KhalidBassiouny1
 
KSD_L8_CMB06.ppt
KSD_L8_CMB06.pptKSD_L8_CMB06.ppt
KSD_L8_CMB06.ppt
KhalidBassiouny1
 
HSPs.ppt
HSPs.pptHSPs.ppt
enzymes.ppt
enzymes.pptenzymes.ppt
enzymes.ppt
KhalidBassiouny1
 
Classification_of_protein_structure.ppt
Classification_of_protein_structure.pptClassification_of_protein_structure.ppt
Classification_of_protein_structure.ppt
KhalidBassiouny1
 
chapter6.ppt
chapter6.pptchapter6.ppt
chapter6.ppt
KhalidBassiouny1
 
class_L02.ppt
class_L02.pptclass_L02.ppt
class_L02.ppt
KhalidBassiouny1
 
centoni (2).ppt
centoni (2).pptcentoni (2).ppt
centoni (2).ppt
KhalidBassiouny1
 
Background.ppt
Background.pptBackground.ppt
Background.ppt
KhalidBassiouny1
 
2005_lecture_01.ppt
2005_lecture_01.ppt2005_lecture_01.ppt
2005_lecture_01.ppt
KhalidBassiouny1
 
Amino_Acids_and_Proteins.ppt
Amino_Acids_and_Proteins.pptAmino_Acids_and_Proteins.ppt
Amino_Acids_and_Proteins.ppt
KhalidBassiouny1
 
142 proteinsoutline.ppt
142 proteinsoutline.ppt142 proteinsoutline.ppt
142 proteinsoutline.ppt
KhalidBassiouny1
 

More from KhalidBassiouny1 (20)

05lipids2009.ppt
05lipids2009.ppt05lipids2009.ppt
05lipids2009.ppt
 
2-lipid.ppt
2-lipid.ppt2-lipid.ppt
2-lipid.ppt
 
2-12-2012-2.ppt
2-12-2012-2.ppt2-12-2012-2.ppt
2-12-2012-2.ppt
 
2-12-2012.ppt
2-12-2012.ppt2-12-2012.ppt
2-12-2012.ppt
 
PeptidesandProteins.ppt
PeptidesandProteins.pptPeptidesandProteins.ppt
PeptidesandProteins.ppt
 
PBIO4500 Protein Therapeutics.ppt
PBIO4500 Protein Therapeutics.pptPBIO4500 Protein Therapeutics.ppt
PBIO4500 Protein Therapeutics.ppt
 
Nut_Chapter_6_lecture.ppt
Nut_Chapter_6_lecture.pptNut_Chapter_6_lecture.ppt
Nut_Chapter_6_lecture.ppt
 
Lh6Ch03aAAs.ppt
Lh6Ch03aAAs.pptLh6Ch03aAAs.ppt
Lh6Ch03aAAs.ppt
 
Lecture 14 2013.ppt
Lecture 14 2013.pptLecture 14 2013.ppt
Lecture 14 2013.ppt
 
KSD_L8_CMB06.ppt
KSD_L8_CMB06.pptKSD_L8_CMB06.ppt
KSD_L8_CMB06.ppt
 
HSPs.ppt
HSPs.pptHSPs.ppt
HSPs.ppt
 
enzymes.ppt
enzymes.pptenzymes.ppt
enzymes.ppt
 
Classification_of_protein_structure.ppt
Classification_of_protein_structure.pptClassification_of_protein_structure.ppt
Classification_of_protein_structure.ppt
 
chapter6.ppt
chapter6.pptchapter6.ppt
chapter6.ppt
 
class_L02.ppt
class_L02.pptclass_L02.ppt
class_L02.ppt
 
centoni (2).ppt
centoni (2).pptcentoni (2).ppt
centoni (2).ppt
 
Background.ppt
Background.pptBackground.ppt
Background.ppt
 
2005_lecture_01.ppt
2005_lecture_01.ppt2005_lecture_01.ppt
2005_lecture_01.ppt
 
Amino_Acids_and_Proteins.ppt
Amino_Acids_and_Proteins.pptAmino_Acids_and_Proteins.ppt
Amino_Acids_and_Proteins.ppt
 
142 proteinsoutline.ppt
142 proteinsoutline.ppt142 proteinsoutline.ppt
142 proteinsoutline.ppt
 

Recently uploaded

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 

Recently uploaded (20)

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 

51071.ppt

  • 1. Global Cancer Epidemic: Impact, Challenges and Future Trends Thomas Gross, MD, PhD Deputy Director of Science Center for Global Health National Cancer Institute Bethesda, MD 20892 Email: thomas.gross@nih.gov
  • 2. Summary of Presentation • Cancer rates, cancer types & cancer mortality vary widely around the world • Eight environmental or lifestyle risk factors that account for ~50% of all cancer deaths • Tobacco exposure is by far the most prominent • Strategies to reduce these risk factors will have a tremendous impact on reducing the burden of cancer globally • Socioeconomic factors affect cancer rates and mortality and will become a bigger challenge in the future
  • 3. Fast Facts About Cancer • Cancer is a global epidemic and a leading cause of death worldwide, accounting for 7.6 million deaths or around 13% of all deaths in 2008. • Worldwide, cancer now causes more deaths than HIV/AIDS, tuberculosis, and malaria combined. • More than 70% of all cancer deaths occur in low- and middle-income countries.
  • 4. CANCER RATES, TYPE AND MORTALITY VARIES WORLDWIDE
  • 5. Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90 The Worldwide Burden of Cancer in Men (Top 10 Cancer Sites) Total: 6,629,100 Total: 4,225,700
  • 6. Most Common Cancer Site in Males Source: GLOBOCAN 2008 via the American Cancer Society
  • 7. Data Source: Jemal, A. et al., CA CANCER J CLIN 2011;61:69–90 The Worldwide Burden of Cancer in Women (Top 10 Cancer Sites) Total: 4,225,700 Total: 3,345,800
  • 8. Most Common Cancer Site in Females Source: GLOBOCAN 2008 via the American Cancer Society
  • 10. 80.3 65.9 34.1 33 32.7 25.2 21.5 20.9 19.2 17.7 17.2 17.1 14.7 13.9 13.3 12.3 11 7.1 4.6 3.3 0 10 20 30 40 50 60 70 80 90 Japan, Hiroshima Korea China, Shanghai USA, Los Angeles: Korean Russia, St Petersburg Peru, Trujillo Singapore: Chinese Slovenia Brazil, Cuiaba Poland, Cracow USA, Hawaii: Japanese USA, Los Angeles: Japanese China, Hong Kong Switzerland, Ticino France, Manche Spain, Zaragoza USA, SEER (9): Black Algeria, Setif India, Mumbai Egypt, Gharbiah Rate per 100,000 Male Stomach Cancer ASRs from Population-based Registries: Data Source: Curado. M. P., Edwards, B., Shin. H.R., Storm. H., Ferlay. J., Heanue. M. and Boyle. P., eds (2007) Cancer Incidence in Five Continents, Vol. IX IARC Scientific Publications No. 160, Lyon, IARC. http://www-dep.iarc.fr/ Genetic Pre-disposition vs Environment Exposure
  • 11. Eight Risk Factors Account for 50% of Deaths from Cancer
  • 12. Risk Factors Vary In Their Contribution To Cancers In Different Settings Percentage of Cancers Attributable to Risk Factor Source: The Cancer Atlas
  • 13. Diseases Associated with Tobacco Exposure Lung Oral Bladder Larynx Esophagus Pancreas Colorectal Stomach Leukemia Cervix Sudden infant death Fetal death, stillbirth Reduced fertility Low birth weight Pregnancy complications Lung function in infants Cardiovascular Diseases Respiratory Diseases Asthma control Low bone density Erectile Dysfunction Peptic ulcer disease Dental diseases The Health Consequences of Smoking: A Report of the Surgeon General , 2004 Cancers Other Medical Conditions
  • 14. Infections cause about: • 18% of cancers globally (>2 million cases/year) • 26% of cancers in LMICs • 40% of cancers in Africa
  • 15. (from Worldmapper, www.worldmapper.org Territories are sized in proportion to the absolute number of people who died from liver cancer annually Liver Cancer Kills 1% of the World’s Population Cancer of the liver cause ~1% of all deaths worldwide (~100 deaths per million people per year) and 9% of all deaths from cancer. S. Korea China Taiwan Japan India 10
  • 16. IMPACT OF SOCIOECONOMIC STATUS ON CANCER BURDEN
  • 17. Data Source: Globocan 2008 Overall (non-adjusted) Cancer Incidence Rates (Per 100K, Both Genders; All Cancers Except Non-Melanoma Skin)
  • 18. Annual Cancer Cases (Millions) 5.7 7.4 7.5 12.9 0 5 10 15 20 25 2010 2030 Less Developed More Developed 57% 64% Trends in Cancer Incidence Developed vs. Less Developed Countries Data derived from GLOBOCAN 2008 0 500 1000 1500 2000 2500 Ages < 20 Ages 20-49 Ages 50-64 Ages 65-74 Ages 75+ Data from SEER 2010 Cancer incidence with age in USA
  • 19. Cancer in 0-14 yr olds as % of all cancer Globocan 2002 % of All Cancers • Incidence per capita of pediatric cancer is similar around the world
  • 20. Trends in Cancer Mortality Developed vs. Less Developed Countries  Cancer mortality in more developed countries  projected decrease by <30% by 2030  Cancer mortality in less developed countries  projected to increase by >70% by 2030 By 2030 - 85% of all cancer deaths may be occurring in low-middle income countries  The increase In cancer mortality in LMIC is largely due to:  Delay in accurate diagnoses  Lack of unawareness about cancer and potential value of therapy  Lack of access and ability to deliver potentially curative therapy  Abandonment of therapy
  • 21. Data Source: Globocan 2008 Female Breast Cancer Incidence (Per 100,000) Total Expenditure on Health (for 2011 in US$) Breast Cancer and Socioeconomic Status
  • 22. RISK FACTORS FOR BREAST CANCER IN DEVELOPED COUNTRIES • Higher maternal age at first birth • Reduced parity – Each live birth results in a decrease of 7% in relative risk of breast cancer (Lancet 2002;360:187-195) • Reduced breast feeding – For every 12 months of breast feeding results in a decrease of 4% in relative risk of breast cancer (Lancet 2002;360:187-195) • Obesity & “lifestyle” factors
  • 23. Incidence of Breast Cancer & Outcomes Correlate with GDP Source: Harford JB, Lancet Oncol. 2011 Mar;12(3):306-12.
  • 24. Institute of Medicine (IOM REPORT) High-income countries should: •Resist the temptation to focus on exporting the latest, most expensive technologies that may be appropriate for wealthy countries… •Partner with countries to develop resource- appropriate strategies focused on decreasing the burden and mortality due to cancer. IOM Report Some low- or middle income countries (including physicians & governments) have a related temptation to WANT the latest, most expensive technologies as opposed to more resource-appropriate “alternatives” which may be seen as 2nd rate solutions.
  • 25. A National Cancer Control Program in Context Broader Social Context Healthcare System National Cancer Control Program Primary Prevention Early Detection Palliative Care Curative Treatment Survivorship
  • 26. This is for title • This is for text NCI - CGH Global Footprint
  • 27. Acknowledgments • Ted Trimble, MD, MPH – Director of NCI-CGH • Lisa Stevens, PhD – Deputy Director of NCI-CGH • Joe Harford, PhD - Senior Advisor NCI-CGH • Ann Chao, PhD – East Asia Representative, NCI-CGH

Editor's Notes

  1. 19